Objectives: Acinetobacter baumannii is an opportunistic nosocomial pathogen and a cause of severe infections in hospitalized patients, owing to its ability to acquire drug resistance by the efflux pump mechanism. The current study investigated the detection and prevalence of efflux pump genes (AdeABC) in multidrug resistant A. baumannii isolates and the role of these genes in multidrug and carbapenems resistance. Methods: This study was conducted on 84 multidrug resistant and 13 carbapenem-susceptible A. baumannii isolates obtained from burn and wound infections in Baghdad hospitals, Iraq. The AdeABC genes were detected by polymerase chain reaction (PCR) assay. Phe-arg-beta-naphthylamide (PAβN)-based method was used for determination of efflux pump activity. Results: This study showed high prevalence of efflux pump genes in our local isolates. The AdeB gene was present in all multidrug resistant isolates (100%) while AdeRS gene was found in 95.2%, AdeC gene in 83.3% and AdeA gene in 77.4%. By comparing the prevalence of these gene in carbapenem-susceptible isolates, it was demonstrated that the gene AdeB was absent in all susceptible isolates, also the regulatory gene AdeRS was not found in most of these isolates, while the other genes (AdeA and AdeC) were detected in most carbapenem-susceptible isolates. Susceptibility of isolates to Amikacin, Gentamicin, Ciprofloxacin, Levofloxacin, Tetracycline and Tigecycline was highly increased in the presence of efflux pump inhibitor, so that, PAβN reduced the minimum inhibitory concentrations (MICs) by 4 to 32 folds. Also, MICs of carbapenems were reduced in the presence of the inhibitor by two to eight folds, while the MICs of colistin were not affected. Conclusions: AdeABC efflux system plays a vital role in multidrug resistance in clinical A. baumannii isolates. It was noted that the most important gene responsible for multidrug resistance within this system was the AdeB gene especially in carbapenems resistance.
Background
Acinetobacter baumannii has become the main cause of nosocomial infections worldwide due to its propensity to rapidly acquire resistance determinants to a wide range of antibiotics (1) . The most prevalent A. baumannii multidrug resistance (MDR) determinants include efflux pumps genes, beta-lactamases, integrons, and insertion sequence (IS) elements (2) . Efflux systems pump several compounds, including antibiotics, out of the bacterial cell and can play a major role in bacterial resistance to different classes of antibiotics (3) . In Acinetobacter, the chromosomally encoded pump is a tripartite efflux machinery that belongs to the RND -type superfamily. The AdeABC efflux pump (RNDtype superfamily) consists of adeA (membrane fusion), adeB (multidrug transporter) and adeC (outer membrane) genes. These three genes are contiguous and adjacent by two-component regulatory systems; adeR and adeS (4) . The major efflux mechanism associated with carbapenem resistance in A. baumannii is the chromosomally encoded tripartite efflux pump, AdeABC, found in approximately 80% of clinical isolates. Over-expression of this pump confers resistance to aminoglycosides and decreases susceptibility to fluoroquinolones, tetracycline, chloramphenicol, erythromycin, trimethoprim and ethidium bromide, as well as to netilmicin and meropenem (5) . The synergy between acquired oxacillinases and the AdeABC pump has been reported and implicated in higher levels of resistance to β-lactams, including carbapenems (4).
Objectives
The aims of this study were to estimate the prevalence of the AdeABC genes in multidrug resistant A. baumannii isolates and the role of the efflux pump in multidrug and carbapenems resistance of A. baumannii strains isolated from burn and wound infections in Baghdad hospitals.
Methods

Bacterial Isolates and Antimicrobial Susceptibility Tests
From February to July 2015, a total of 96 A. baumannii clinical isolates were recovered from 476 burn and wound infections from patients in Baghdad hospitals, Iraq. The clinical isolates were identified according to conventional biochemical tests, API20 E and Vitek2 system. The BlaOXA-51 gene was also detected for confirming the identification (6) . Antimicrobial susceptibility tests were performed using Disc diffusion method and minimal inhibitory concentrations (MICs) using the microdilution method in Mueller-Hinton broth based on the results reported by the Clinical and Laboratory Standards Institute (CLSI) guidelines (7) . Pseudomonas aeruginosa ATCC-27853 was used for quality control in antimicrobial susceptibility testing (8). µg/mL constant PβNA (Phe-arg-beta-naphthylamide) concentration was obtained by adding 40 µL of the bacterial suspension and 10 µL of the stock PβNA (200 µg/mL) solution to each well. Fold decrease in the MIC values of each antibiotic was evaluated as the effect of the efflux pump inhibitor (9).
Detection of the Efflux Pump-Mediated Antibiotic Resistance
Detection of AdeABC Efflux Pump System by the Polymerase Chain Reaction
Acinetobacter baumannii isolates were assayed for Ade-ABC genes by PCR with primers previously described (Table 1). The amplification conditions of AdeA gene were as follows: initial denaturation at 94°C for five minutes, 30 cycles of 94°C for one minute, 56°C for one minute, 72°C for one minute and final elongation at 72°C for seven minutes (10) . The amplification conditions of AdeB gene were as follows: initial denaturation at 94°C for two minutes, 35 cycles at 94°C for 30 seconds, 55°C for 30 seconds, 72°C for two minutes and final elongation at 72°C for two minutes (11) . The AdeC and AdeRS genes were amplified using the following conditions: initial denaturation at 94°C for five minutes, 35 cycles of 94°C for 30 seconds, 57°C for 40 seconds and 72°C for 50 seconds and a final elongation at 72°C for six minutes (12).
Agarose Gel Electrophoresis
Gel electrophoresis was used for the detection of PCR products, visualized with the aid of ethidium bromide and UV transilluminator documentation system. The size of PCR products was compared with a 100-bp DNA Ladder (Bioneer, Korea).
Statistical Analysis
SPSS software version 16 was used for analysis by conducting Chi-square test. Differences between values were considered significant at P ≤ 0.01.
Results and Discussion
Detection and Distribution of AdeABC Efflux Pump Genes
In our previous reports, 96 isolates were identified as A. baumannii, 84 of these isolates were multidrug resistant and 13 isolates were carbapenems susceptible (6, 8) . Genes encoding efflux pumps in all 84 multidrug resistant A. baumannii isolates were determined by PCR assay, efflux pump adeA, adeB and adeC genes, and their regulator adeRS gene was detected in these isolate (Figure 1 ). These genes were also detected in 13 carbapenem-susceptible A. baumannii isolates.
Polymerase Chain Reaction assay was performed with specific primers detection genes of AdeABC system. Amplification fragments with sizes of approximately 513 bp, 981 bp, 560 bp and 790 bp were detected on agarose gel that corresponded to adeA, adeB, adeC and adeRS genes, respectively.
The distribution of efflux pump in multidrug-resistant isolates (n = 84) is shown in Table 2 .
The results of this study revealed the dominance of adeB gene among multidrug resistant A. baumannii strains (MDRAB) isolated from burn and wound infections, and prevalence of this gene in these isolates was 100%. Also the results demonstrated the presence of regulator gene adeRS in 95.2% of the MDRAB isolates. From a total of 84 MDRAB isolates, the number of isolates, which carried the gene adeC were 70 isolates (83.3%), while the lowest percentage of these genes was recorded for adeA gene (77.4%), (high significant differences at P < 0.01).
The novelty of the current study was to detect and determine the prevalence of efflux pump genes in MDR A. baumannii in Baghdad hospitals.
Previous study by Japoni Nejad et al. (13) from Iran reported that from a total of 56 multidrug resistant isolates of A. baumannii, the adeA, adeB and adeC genes were detected in 100%, 100% and 96.5% of isolates, respectively and all isolates were resistant to cefotaxim, ceftazidim, cefepim, cefoxitin, azteronam, ciprofloxacin and imipenem. In another conducted study from Iran on 60 A. baumannii isolates from burn units, the results revealed the detection of adeA and adeB genes in all isolates (100%) while AdeC was present in 51 isolates (85%) (14) . In another study by Hou et al. (15) it was found that adeB, adeR, adeS, adeJ and abeM were found in the majority of imipenem resistant A. baumannii (> 80% 
The role of AdeABC Efflux Pump Genes in Multidrug and Carbapenems Resistance
It was found from our results of detection of AdeABC efflux system that the most multidrug resistant isolates possessed all genes of the system but it was obvious that adeB gene had the main role in the resistance mechanism. To determinate the role of efflux pump in the multidrug resistant phenotypes in A. baumannii isolates, the experiment included detection of the MICs of 12 antibiotics in the presence of 20 µg/mL of PβNA, and then, compared the MICs with and without PβNA ( Table 3) .
The effect of Phe-Arg-Beta-Naphthylamide (PAβN) on MICs of A. baumannii is summarized in Table 3 ; it was found that the addition of the PAβN at a final concentration of 20 µg/mL greatly reduced the MICs of amikacin from four to eight folds and gentamicin from 8 to 32 folds. Also the effect of PAβN on MICs of fluoroquinolone (ciprofloxacin and levofloxacin) and tetracycline antibiotics was obvious with reduction in MICs from 4 to 16 folds. It was noted that after exposure to the efflux pump inhibitor, two to eight fold reduction in the MICs of carbapenems was observed. The minimal effect of the inhibitor was correlated with antibiotics colistin, ceftazidime and cefotaxime.
The effects of efflux pump inhibitors such as carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and PheArg-Beta-Naphthylamide (PAβN) on antimicrobial susceptibility were investigated in some studies (4, 21) . One of the reports revealed that the addition of the Phe-arg-betanaphthylamide at different concentrations reduced the MICs of different antibiotics such as ertapenem (22) . Ardebili et al. (21) found that the addition of efflux pump inhibitor CCCP caused an increase in the susceptibility to ciprofloxacin by 4 to 64 folds. Our results suggested that drug efflux pumps contribute to the resistance to fluoroquinolone in A. baumannii clinical isolates.
It was reported that the imipenem susceptibility of most A. baumannii isolated from burns was increased in the presence of the PAβN by 4 to 64 folds (14) . Our results indicated the role of efflux pump mechanism in imipenem and meropenem resistance in A. baumannii isolates. Several studies indicated the role of the AdeABC system in the resistance of A. baumannii to many classes of antibiotics such as beta-lactams, aminoglycosides, quinolones and tetracycline (23) .
The prevalence of efflux pump genes among 13 carbapenem-susceptible A. baumannii isolates is summarized in Table 4 , in order to study the role of efflux pump genes in the resistance of carbapenems. It was found that all 13 isolates lacked the AdeB gene while AdeRS gene was present only in five isolates. AdeA and AdeC genes were found in most sensitive isolates.
An efflux pump system AdeABC seems to play an important role in the resistance to imipenem of A. baumannii. After exposure to the efflux pump inhibitor, Phe-Arg-β-naphthylamide, a significant reduction of imipenem MICs was observed in 33 (66%) isolates of IRAB, while no significant decrease occurred in Imipenem-Susceptible A. baumannii (ISAB) (15) . The results conducted by Jia et al. (17) showed that isolates carrying blaOXA-23 and AdeABC efflux pump genes were the most prevalent in MDR A. baumannii and the co-expression of carbapenemase and efflux pump proteins are considered the main reason for the resistance of these bacteria in the intensive care unit (ICU). Our results are concordant with the findings of Marchand et al. (4), who claimed that adeC gene is not essential for the MDR A. baumannii phenotype resulted from the efflux pump, since an inactivation of adeC gene will not change the resistance of bacteria to different antibiotics. Another study suggested that OXA-23 carbapenemase encoded by the blaOXA-23 gene on the chromosome and overexpression of the AdeABC efflux pump may contribute to carbapenem resistance in clinical isolates of A. baumannii (24) . It was shown that the present results disagree with the data of some previous studies, which indicated that AdeABC efflux pump genes existed in both carbapenem-resistant and sensitive strains, therefore they may not have contributed to the carbapenems resistance of A. baumannii (25, 26) .
The current study demonstrated the main contribution of the gene adeB and its regulatory system in multidrug and carbapenems resistance in clinical isolates of A. baumannii. The high levels of carbapenem-resistance in A. baumannii might be due to the cooperation among blaOXA and AdeABC genes.
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